US3980766A
(en)
|
1973-08-13 |
1976-09-14 |
West Laboratories, Inc. |
Orally administered drug composition for therapy in the treatment of narcotic drug addiction
|
DE2530563C2
(de)
|
1975-07-09 |
1986-07-24 |
Bayer Ag, 5090 Leverkusen |
Analgetische Arzneimittel mit vermindertem Mißbrauchspotential
|
DD146547A5
(de)
|
1978-07-15 |
1981-02-18 |
Boehringer Sohn Ingelheim |
Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
|
US4423099A
(en)
|
1980-07-28 |
1983-12-27 |
Ciba-Geigy Corporation |
Membrane modified hydrogels
|
IT1153487B
(it)
|
1982-04-15 |
1987-01-14 |
Prophin Lab Spa |
Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
|
GB8521494D0
(en)
|
1985-08-29 |
1985-10-02 |
Zyma Sa |
Controlled release tablet
|
IT1201136B
(it)
|
1987-01-13 |
1989-01-27 |
Resa Farma |
Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
|
FI101344B
(fi)
|
1988-03-31 |
1998-06-15 |
Tanabe Seiyaku Co |
Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseut tisesti aktiivista ainetta
|
US4996047A
(en)
|
1988-11-02 |
1991-02-26 |
Richardson-Vicks, Inc. |
Sustained release drug-resin complexes
|
US5206030A
(en)
|
1990-02-26 |
1993-04-27 |
Fmc Corporation |
Film-forming composition and use for coating pharmaceuticals, foods and the like
|
US5958459A
(en)
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
US5681585A
(en)
|
1991-12-24 |
1997-10-28 |
Euro-Celtique, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
SE9301057L
(sv)
|
1993-03-30 |
1994-10-01 |
Pharmacia Ab |
Beredning med kontrollerad frisättning
|
GB9401894D0
(en)
|
1994-02-01 |
1994-03-30 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
US5395626A
(en)
|
1994-03-23 |
1995-03-07 |
Ortho Pharmaceutical Corporation |
Multilayered controlled release pharmaceutical dosage form
|
US5484608A
(en)
|
1994-03-28 |
1996-01-16 |
Pharmavene, Inc. |
Sustained-release drug delivery system
|
AT403988B
(de)
|
1994-05-18 |
1998-07-27 |
Lannacher Heilmittel |
Festes orales retardpräparat
|
US6491945B1
(en)
|
1994-09-16 |
2002-12-10 |
Alza Corporation |
Hydrocodone therapy
|
US5645858A
(en)
|
1994-10-06 |
1997-07-08 |
Ortho Pharmaceutical Corporation |
Multilayered controlled release pharmaceutical dosage form
|
AUPN603895A0
(en)
|
1995-10-19 |
1995-11-09 |
University Of Queensland, The |
Production of analgesic synergy by co-administration of sub-analgesic doses of two strong opioids
|
DE19630035A1
(de)
|
1996-07-25 |
1998-01-29 |
Asta Medica Ag |
Tramadol Multiple Unit Formulierungen
|
US6066339A
(en)
|
1997-10-17 |
2000-05-23 |
Elan Corporation, Plc |
Oral morphine multiparticulate formulation
|
WO1999032119A1
(en)
|
1997-12-22 |
1999-07-01 |
Euro-Celtique, S.A. |
Opioid agonist/antagonist combinations
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
SE9803871D0
(sv)
|
1998-11-11 |
1998-11-11 |
Pharmacia & Upjohn Ab |
Therapeutic method and formulation
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
DE19856147A1
(de)
*
|
1998-12-04 |
2000-06-08 |
Knoll Ag |
Teilbare feste Dosierungsformen und Verfahren zu ihrer Herstellung
|
ATE260642T1
(de)
|
1998-12-17 |
2004-03-15 |
Alza Corp |
Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
|
FR2787715B1
(fr)
|
1998-12-23 |
2002-05-10 |
Synthelabo |
Composition pharmaceutique comprenant un compose hypnotique ou un de ses sels pharmaceutiquement acceptables
|
US20030118641A1
(en)
|
2000-07-27 |
2003-06-26 |
Roxane Laboratories, Inc. |
Abuse-resistant sustained-release opioid formulation
|
US6753011B2
(en)
|
2000-01-14 |
2004-06-22 |
Osmotica Corp |
Combined diffusion/osmotic pumping drug delivery system
|
HU229705B1
(en)
|
2000-02-08 |
2014-05-28 |
Euro Celtique Sa |
Tamper-resistant oral opioid agonist formulations
|
AR030557A1
(es)
|
2000-04-14 |
2003-08-27 |
Jagotec Ag |
Una tableta en multicapa de liberacion controlada y metodo de tratamiento
|
US6419954B1
(en)
|
2000-05-19 |
2002-07-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Tablets and methods for modified release of hydrophilic and other active agents
|
US6720005B1
(en)
|
2000-07-07 |
2004-04-13 |
The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University |
Coated, platform-generating tablet
|
CN1610551A
(zh)
|
2001-07-06 |
2005-04-27 |
恩德制药公司 |
用作止痛剂的6-羟基羟吗啡酮的肠胃外给药
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
KR20040060917A
(ko)
|
2001-08-06 |
2004-07-06 |
유로-셀티크 소시에떼 아노뉨 |
오피오이드 남용을 방지하기 위한 조성물 및 방법
|
US7842307B2
(en)
|
2001-08-06 |
2010-11-30 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
|
US20070066537A1
(en)
|
2002-02-22 |
2007-03-22 |
New River Pharmaceuticals Inc. |
Compounds and compositions for prevention of overdose of oxycodone
|
US20060014697A1
(en)
|
2001-08-22 |
2006-01-19 |
Travis Mickle |
Pharmaceutical compositions for prevention of overdose or abuse
|
WO2003020242A1
(en)
|
2001-08-29 |
2003-03-13 |
Srl Technologies, Inc. |
Sustained release preparations
|
US20030092724A1
(en)
|
2001-09-18 |
2003-05-15 |
Huaihung Kao |
Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
|
MXPA04002980A
(es)
|
2001-09-28 |
2005-06-20 |
Johnson & Johnson |
Formas de dosificacion que tienen un nucleo interior y coraza exterior con diferentes formas.
|
IL162870A0
(en)
|
2002-02-01 |
2005-11-20 |
Pfizer Prod Inc |
Controlled release pharmaceutical dosage forms of a cholesteryl estertransfer protein inhibitor
|
KR100540035B1
(ko)
*
|
2002-02-01 |
2005-12-29 |
주식회사 태평양 |
다단계 경구 약물 방출 제어 시스템
|
ES2500117T3
(es)
|
2002-02-22 |
2014-09-30 |
Shire Llc |
Novedosos compuestos farmacéuticos de liberación sostenida para prevenir el abuso de sustancias controladas
|
EP2243471A1
(en)
|
2002-04-05 |
2010-10-27 |
Euro-Celtique S.A. |
Matrix for sustained, invariant and independent release of active compounds
|
JP4694207B2
(ja)
|
2002-07-05 |
2011-06-08 |
コルジウム ファーマシューティカル, インコーポレイテッド |
オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
|
US8557291B2
(en)
|
2002-07-05 |
2013-10-15 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent pharmaceutical compositions of opioids and other drugs
|
ES2358896T3
(es)
|
2002-08-15 |
2011-05-16 |
Euro-Celtique S.A. |
Composiciones farmacéuticas que comprenden un analgésico opioide.
|
EP1545468A4
(en)
|
2002-09-20 |
2007-06-20 |
Alpharma Inc |
SUSTAINED RELEASE OPIOID PREPARATIONS AND METHODS OF USE
|
DK1551372T3
(en)
|
2002-09-20 |
2018-07-23 |
Alpharma Pharmaceuticals Llc |
SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES
|
JP5189242B2
(ja)
|
2002-09-23 |
2013-04-24 |
アルケルメス ファーマ アイルランド リミテッド |
乱用抵抗性の医薬組成物
|
DE10250084A1
(de)
|
2002-10-25 |
2004-05-06 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
DK1575569T3
(da)
|
2002-12-13 |
2011-01-10 |
Durect Corp |
Oralt indgivelsessystem omfattende flydende bærematerialer med høj viskositet
|
US8906413B2
(en)
|
2003-05-12 |
2014-12-09 |
Supernus Pharmaceuticals, Inc. |
Drug formulations having reduced abuse potential
|
KR101170840B1
(ko)
|
2003-05-29 |
2012-08-03 |
샤이어 엘엘씨 |
남용 방지성 암페타민 화합물
|
AU2003279702A1
(en)
|
2003-08-12 |
2005-03-10 |
Endo Pharmaceuticals, Inc. |
Method for deterring abuse of opioids by combination with non-release formulation of emetic
|
JP5563731B2
(ja)
|
2003-09-26 |
2014-07-30 |
アルザ・コーポレーシヨン |
オピオイドおよび非オピオイド鎮痛薬の制御放出製剤
|
EP1675555A4
(en)
|
2003-09-30 |
2011-03-09 |
Shire Llc |
PHARMACEUTICAL COMPOSITIONS FOR PREVENTING EXCESSIVE DOSE OR ABUSE
|
US20050074493A1
(en)
|
2003-10-03 |
2005-04-07 |
Mehta Atul M. |
Extended release formulations of opioids and method of use thereof
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
WO2005055981A2
(en)
|
2003-12-09 |
2005-06-23 |
Euro-Celtique S.A. |
Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same
|
US20050163843A1
(en)
|
2003-12-31 |
2005-07-28 |
Garth Boehm |
Alprazolam formulations
|
US20050191349A1
(en)
*
|
2003-12-31 |
2005-09-01 |
Garth Boehm |
Galantamine formulations
|
WO2006079550A2
(en)
|
2005-01-28 |
2006-08-03 |
Euro-Celtique S.A. |
Alcohol resistant dosage forms
|
NZ549838A
(en)
|
2004-03-26 |
2010-04-30 |
Eisai R&D Man Co Ltd |
Coated controlled-release preparation containing a gastric acid secretion inhibitor
|
WO2005094821A1
(fr)
|
2004-03-30 |
2005-10-13 |
Lotus Pharmaceutical Co.,Ltd. |
Composition medicale pour augmenter la securite d'un medicament
|
TWI354569B
(en)
|
2004-05-28 |
2011-12-21 |
Bristol Myers Squibb Co |
Coated tablet formulation and method
|
ES2653568T3
(es)
|
2004-06-12 |
2018-02-07 |
Collegium Pharmaceutical, Inc. |
Formulaciones de fármacos para la prevención del abuso
|
US9884014B2
(en)
*
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
AR051950A1
(es)
|
2004-11-10 |
2007-02-21 |
Osmotica Pharmaceutical Argent |
Comprimido multicapa con capas que se separan
|
US20060110327A1
(en)
|
2004-11-24 |
2006-05-25 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
US20080152595A1
(en)
|
2004-11-24 |
2008-06-26 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
US20060189635A1
(en)
|
2005-02-04 |
2006-08-24 |
Michelle Kramer |
Enhanced efficacy benzisoxazole derivative dosage forms and methods
|
PE20070325A1
(es)
|
2005-06-29 |
2007-05-12 |
Alza Corp |
Formas de dosificacion oral que comprenden compuestos derivados de carbamato
|
WO2007013975A2
(en)
|
2005-07-20 |
2007-02-01 |
Pharmorx Inc. |
Composition containing an opioid agonist and a partial opioid agonist, preferably buprenorphine , for controlling abuse of medications
|
KR101655455B1
(ko)
|
2005-09-09 |
2016-09-07 |
안젤리니 라보팜 엘엘씨 |
일일 1회 투여를 위한 트라조돈 조성물
|
GB0612326D0
(en)
|
2005-10-31 |
2006-08-02 |
Alza Corp |
Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms
|
US20090082466A1
(en)
|
2006-01-27 |
2009-03-26 |
Najib Babul |
Abuse Resistant and Extended Release Formulations and Method of Use Thereof
|
AU2006326377B2
(en)
|
2005-12-13 |
2010-10-07 |
Biodelivery Sciences International, Inc. |
Abuse resistant transmucosal drug delivery device
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
FR2898056B1
(fr)
|
2006-03-01 |
2012-01-20 |
Ethypharm Sa |
Comprimes resistant a l'ecrasement destines a eviter le detournement illicite
|
US20070212414A1
(en)
|
2006-03-08 |
2007-09-13 |
Penwest Pharmaceuticals Co. |
Ethanol-resistant sustained release formulations
|
CN101400343B
(zh)
|
2006-03-16 |
2012-01-11 |
特瑞斯制药股份有限公司 |
含有药物-离子交换树脂复合物的经修饰释放的制剂
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
US9023400B2
(en)
*
|
2006-05-24 |
2015-05-05 |
Flamel Technologies |
Prolonged-release multimicroparticulate oral pharmaceutical form
|
US20080069891A1
(en)
*
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
CN101677963B
(zh)
*
|
2006-06-19 |
2012-05-30 |
奥尔制药公司 |
药物组合物
|
US20080075771A1
(en)
|
2006-07-21 |
2008-03-27 |
Vaughn Jason M |
Hydrophilic opioid abuse deterrent delivery system using opioid antagonists
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
MX2009002235A
(es)
|
2006-08-30 |
2009-03-13 |
Jagotec Ag |
Formulaciones de dosis oral, solidas, de liberacion controlada que comprenden nisoldipina.
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
US20080085305A1
(en)
|
2006-10-10 |
2008-04-10 |
Penwest Pharmaceuticals Co. |
Robust sustained release formulations of oxymorphone
|
DE102006051020A1
(de)
|
2006-10-26 |
2008-04-30 |
Evonik Röhm Gmbh |
Verwendung von (Meth)acrylat-Copolymeren in Retard-Arzneiformen zur Verringerung des Einflusses von Ethanol auf die Wirkstofffreisetzung
|
ES2692437T3
(es)
|
2007-08-13 |
2018-12-03 |
Abuse Deterrent Pharmaceutical Llc |
Fármacos resistentes al abuso, método de uso y método de preparación
|
WO2009036812A1
(en)
|
2007-09-21 |
2009-03-26 |
Evonik Röhm Gmbh |
Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol
|
EP2187875B1
(en)
|
2007-09-21 |
2012-09-05 |
Evonik Röhm GmbH |
Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol
|
TW200950776A
(en)
|
2008-01-24 |
2009-12-16 |
Abbott Gmbh & Co Kg |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20100099696A1
(en)
|
2008-10-16 |
2010-04-22 |
Anthony Edward Soscia |
Tamper resistant oral dosage forms containing an embolizing agent
|
EP2364143A1
(en)
|
2008-10-31 |
2011-09-14 |
McNeil-PPC, Inc. |
Osmotic tablet with a compressed outer coating
|
CA2746888C
(en)
*
|
2008-12-16 |
2015-05-12 |
Labopharm (Barbados) Limited |
Misuse preventative, controlled release formulation
|
JP5619130B2
(ja)
*
|
2009-03-18 |
2014-11-05 |
エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツングEvonik RoehmGmbH |
中性ビニルポリマーおよび賦形剤を含むコーティングを使用するエタノールの影響に対する耐性を有する制御放出性医薬組成物
|
JP5845173B2
(ja)
*
|
2009-05-01 |
2016-01-20 |
アデア ファーマスーティカルズ,インコーポレイテッド |
非オピオイドおよびオピオイド鎮痛薬の組み合わせを含む口腔内崩壊錠組成物
|
JP5827952B2
(ja)
*
|
2009-10-09 |
2015-12-02 |
ユンジン・ファーム・カンパニー・リミテッドYungjin Pharm. Co. Ltd. |
速効性と持続性を同時に有する薬剤学的組成物
|